|
⚲
|
| Keyboard |
| Shaaltiel Yoseph
✚
|
|
|---|---|
| CIK # | 0001385118 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001385118] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Protalix BioTherapeutics Inc | |
| Shaaltiel Yoseph |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2018-09-13 | Grant | 700,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2016-09-15 | Option exercise | 122,162 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2016-09-15 | Option exercise | 122,162 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2015-03-23 | Grant | 275,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-07-16 | Grant | 210,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Sell | 300,000 | $7.13 | 2,139,000 |